Skip to search formSkip to main contentSkip to account menu

Imagopaque

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
1 Sterling JC, Kurtz JB. Viral infection. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds), 6th… 
1997
1997
Abstract.Objectives: Iopentol (Nycomed Imaging AS, Oslo, Norway) and iopromide (Schering AG, Berlin, Germany) are low-osmolar… 
1997
1997
Summary.Objectives. This trial was designed to compare the incidence of delayed postprocedural pain after administration of… 
1997
1997
Abstract. The elimination of the non-ionic contrast medium iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) from the… 
Review
1997
Review
1997
Abstract. The aims of the present open, non-comparative survey were to study the safety and efficacy of iopentol (Imagopaque… 
1997
1997
Summary. The non-ionic contrast medium iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) 350 mg I/ml was compared for… 
1997
1997
Summary. The efficacy and safety of the non-ionic contrast medium iopentol, 250 mg I/ml (Imagopaque®, Nycomed Imaging AS, Oslo… 
1997
1997
Summary. Iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) 300 mg I/ml was compared with iopromide (Ultravist®, Schering… 
1994
1994
In pediatric radiology there is a great demand for a safe contrast medium. In this pediatric CT trial, the safety, tolerability…